We are live on ! Find out more
MGNX icon

MacroGenics

144 hedge funds and large institutions have $528M invested in MacroGenics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 38 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,211% more call options, than puts

Call options by funds: $498K | Put options by funds: $38K

53% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 38

4.96% more ownership

Funds ownership: 93.38%98.34% (+5%)

8% less funds holding

Funds holding: 156144 (-12)

38% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 32

43% less capital invested

Capital invested by funds: $918M → $528M (-$390M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
144
Holders Change
-12
Holders Change %
-7.69%
% of All Funds
2.27%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
20
Increased
58
Reduced
38
Closed
32
Calls
$498K
Puts
$38K
Net Calls
+$460K
Net Calls Change
-$160K
Name Holding Trade Value Shares
Change
Change in
Stake
N
26
Nuveen
North Carolina
$2.66M -$428K -38,731 -11%
Federated Hermes
27
Federated Hermes
Pennsylvania
$2.56M +$3.21M +290,458 New
RPAM
28
Rhenman & Partners Asset Management
Sweden
$2.53M -$150K -13,572 -5%
JP Morgan Chase
29
JP Morgan Chase
New York
$2.5M +$2.07M +187,724 +195%
WP
30
Woodline Partners
California
$2.37M
Principal Financial Group
31
Principal Financial Group
Iowa
$2.37M +$110K +9,995 +4%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$2.17M +$2.35M +212,900 +641%
SC
33
Sessa Capital
New York
$2.16M +$2.7M +244,864 New
PAM
34
Panagora Asset Management
Massachusetts
$2.15M +$890K +80,604 +49%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$2.12M +$2M +181,203 +305%
Bank of America
36
Bank of America
North Carolina
$1.95M +$1.14M +103,359 +87%
Walleye Capital
37
Walleye Capital
New York
$1.89M +$2.36M +213,978 New
Rafferty Asset Management
38
Rafferty Asset Management
New York
$1.83M +$396K +35,864 +21%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$1.75M +$10K +908 +0.5%
DCM
40
DAFNA Capital Management
California
$1.69M +$1.13M +102,000 +113%
Axa
41
Axa
France
$1.67M +$1.92M +174,200 +1,146%
Jacobs Levy Equity Management
42
Jacobs Levy Equity Management
New Jersey
$1.48M +$1.86M +168,224 New
IC
43
Ikarian Capital
Texas
$1.45M +$89.1K +8,072 +5%
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
$1.35M +$1.11M +100,861 +193%
AllianceBernstein
45
AllianceBernstein
Tennessee
$1.29M +$699K +63,331 +77%
PP
46
PDT Partners
New York
$1.24M +$1.55M +140,325 New
PAMP
47
Polar Asset Management Partners
Ontario, Canada
$1.23M
UBS Group
48
UBS Group
Switzerland
$1.21M -$21.4K -1,940 -1%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$1.16M +$637K +57,700 +78%
CSS
50
Cubist Systematic Strategies
Connecticut
$1.06M +$873K +79,046 +193%

MGNX Hedge Fund Activity: Q1 2022 in Review

144 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2022, worth a combined $528M — down 43% from $918M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of MGNX and 20 opened new positions — a net loss of 12 holders — while 38 trimmed existing stakes and 58 added.

The largest buyer was Armistice Capital, adding an estimated $25.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $20.2M sold.

  • 144 institutional investors held MacroGenics (MGNX) as of Q1 2022, down from 156 in Q4 2021.
  • Funds reported $528M of MacroGenics stock for Q1 2022, down 43% quarter-over-quarter.
  • 20 funds opened new MacroGenics positions in Q1 2022 and 32 closed out, a net change of -12 holders.
  • The largest MacroGenics buyer in Q1 2022 was Armistice Capital, an estimated $25.4M added.
  • The largest MacroGenics seller in Q1 2022 was Point72 Asset Management, an estimated $20.2M sold.

Based on aggregated 13F filings for Q1 2022.